Julen Oyarzabal
Julen Oyarzabal
Integrating academic rigor with investment vision, he is a Partner and CSO at Columbus Venture Partners, following a distinguished career at UCSF, Johnson & Johnson, and CNIO. After leading Translational Sciences at CIMA, he has become a specialist in de-risking therapeutic development. With over 35 patent families and a key role as an expert for the European Medicines Agency (EMA), he now leverages his deep expertise in small-molecule design, synthetic biology and advanced therapies to identify and scale high-impact biotech innovations: from therapeutics to manufacturing.
What do you need?
We're here to help
Do you have any questions?
Contact us and we will try to resolve it as soon as possible.
Do you want to always be up to date?
Subscribe to our newsletter and don't miss any news
Do you have any questions?